文献速递重症综合管理与镇静镇痛

Narcotrend指数与Richmond躁动镇静评分在胰十二指肠切除术后短期机械通气患者镇静评估中的应用:一项随机对照试验

[Application of Narcotrend index and Richmond agitation-sedation score in sedation assessment of patients with short-term mechanical ventilation after pancreatoduodenectomy: a randomized controlled trial].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论在胰十二指肠切除术后短期机械通气患者中,NTI指导的浅镇静较RASS指导可提高浅镇静达标率并缩短机械通气时间。

该研究为前瞻性随机对照试验,纳入2016年1月至2018年12月皖南医学院第一附属医院重症医学科收治的胰十二指肠切除术后机械通气12-48小时患者87例,随机分为NTI指导组(45例)和RASS指导组(42例)进行浅镇静治疗。结果显示NTI组浅镇静后及2、4、6小时浅镇静达标率和累积达标次数均高于RASS组,NTI组右美托咪定用量更高但丙泊酚使用比例和剂量更低,NTI组镇静持续时间和机械通气时间更短,RASS组低血压发生率更高,NTI组应激指标(肾上腺素、去甲肾上腺素、CRP、皮质醇)较低。结论认为NTI监测指导浅镇静能更好达到浅镇静目标。

要点

  • NTI组浅镇静后、2、4、6小时达标率分别为71.1%(32/45)、80.0%(36/45)、88.9%(40/45)、83.9%(642/765),均高于RASS组的50.0%(21/42)、54.8%(23/42)、59.5%(25/42)、62.8%(475/756),P<0.05
  • NTI组镇静持续时间15.68±2.43小时、机械通气时间16.27±2.42小时,均短于RASS组的17.29±2.43小时、18.25±2.04小时,P<0.01
  • NTI组右美托咪定用量0.60±0.10 μg×kg-1×h-1高于RASS组0.54±0.12 μg×kg-1×h-1(P<0.01),但RASS组丙泊酚使用比例64.3%(27/42)和剂量47.82±7.31 mg/h高于NTI组的37.8%(17/45)和30.83±10.35 mg/h(P<0.05)
  • RASS组低血压发生率35.7%(15/42)高于NTI组13.3%(6/45),P<0.05;两组高血压、心动过缓、意外拔管和谵妄无显著差异
  • NTI组浅镇静6小时和拔管后2小时肾上腺素、去甲肾上腺素、CRP水平低于RASS组,浅镇静6小时皮质醇低于RASS组,P<0.05

适用人群与场景

  • 2016年1月至2018年12月皖南医学院第一附属医院重症医学科收治的胰十二指肠切除术后机械通气12-48小时患者
  • 纳入87例,随机分为NTI指导组45例和RASS指导组42例

处置流程与药物剂量

  • NTI组以Narcotrend指数(NTI)指导浅镇静治疗,RASS组以Richmond躁动镇静评分(RASS)指导浅镇静治疗
  • NTI组右美托咪定用量0.60±0.10 μg×kg-1×h-1,RASS组0.54±0.12 μg×kg-1×h-1
  • RASS组丙泊酚使用比例64.3%(27/42)、剂量47.82±7.31 mg/h;NTI组使用比例37.8%(17/45)、剂量30.83±10.35 mg/h

研究设计与关键结果

  • 前瞻性随机对照试验,纳入87例胰十二指肠切除术后机械通气12-48小时患者,NTI组45例、RASS组42例,两组性别、年龄、BMI、肝功能分级、手术时间、出血量、中转开腹和APACHE II评分无显著差异
  • NTI组浅镇静后、2、4、6小时达标率及累积达标次数均高于RASS组:71.1%(32/45)vs. 50.0%(21/42)、80.0%(36/45)vs. 54.8%(23/42)、88.9%(40/45)vs. 59.5%(25/42)、83.9%(642/765)vs. 62.8%(475/756),均P<0.05
  • NTI组右美托咪定用量高于RASS组(0.60±0.10 vs. 0.54±0.12 μg×kg-1×h-1,P<0.01),RASS组丙泊酚使用比例和剂量高于NTI组(64.3%(27/42)vs. 37.8%(17/45);47.82±7.31 vs. 30.83±10.35 mg/h,均P<0.05)
  • NTI组镇静持续时间和机械通气时间短于RASS组(15.68±2.43 vs. 17.29±2.43小时;16.27±2.42 vs. 18.25±2.04小时,均P<0.01)
  • RASS组低血压发生率高于NTI组(35.7%(15/42)vs. 13.3%(6/45),P<0.05);两组高血压、心动过缓、意外拔管和谵妄无显著差异
  • NTI组浅镇静6小时和拔管后2小时肾上腺素、去甲肾上腺素、CRP水平低于RASS组,浅镇静6小时皮质醇低于RASS组,均P<0.05

证据类型、等级与局限

  • 证据类型:前瞻性随机对照试验
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对于胰十二指肠切除术后短期机械通气(12-48小时)患者,作者认为应用NTI监测指导浅镇静治疗能更好达到浅镇静目标

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the feasibility of Narcotrend index (NTI) for digital monitoring of light sedation depth in patients undergoing short-term mechanical ventilation after pancreaticoduodenectomy.

METHODS: A prospective randomized controlled trial was conducted. Patients with mechanical ventilation for 12-48 hours after pancreaticoduodenectomy admitted to department of critical care medicine of the First Affiliated Hospital of Wannan Medical College from January 2016 to December 2018 were enrolled. They were randomly divided into two groups, and NTI and Richmond agitation-sedation score (RASS) were used to guide light sedation treatment respectively. The implementation effect of light sedation, duration of mechanical ventilation, dosage of sedative drugs, occurrence of adverse events (accidental extubation, delirium, cardiovascular events) and stress response [cortisol, epinephrine, norepinephrine, C-reactive protein (CRP)] were compared between the two groups.

RESULTS: A total of 87 patients were enrolled in this study, of whom 45 received NTI-guided sedation assessment and 42 received RASS-guided sedation assessment. There were no significant differences in gender, age, body mass index (BMI), liver function classification, operation time, blood loss, conversion to laparotomy and acute physiology and chronic health evaluation II (APACHE II) score between the two groups. During sedation treatment, the light sedation compliance rate after light sedation, 2, 4, 6 hours and cumulative compliance period number (Dt) in NTI group were higher than those in RASS group [71.1% (32/45) vs. 50.0% (21/42), 80.0% (36/45) vs. 54.8% (23/42), 88.9% (40/45) vs. 59.5% (25/42), 83.9% (642/765) vs. 62.8% (475/756), all P < 0.05]. The dosage of dexmedetomidine in NTI group was higher than that in RASS group (μg×kg-1×h-1: 0.60±0.10 vs. 0.54±0.12, P < 0.01), but more patients in RASS group receiveda larger dose of propofol to maintain sedation [ratio of use of propofol: 64.3% (27/42) vs. 37.8% (17/45), dose of propofol (mg/h): 47.82±7.31 vs. 30.83±10.35, both P < 0.05]. The sedation duration and duration of mechanical ventilation in NTI group were lower than those in RASS group (hours: 15.68±2.43 vs. 17.29±2.43, 16.27±2.42 vs. 18.25±2.04, both P < 0.01). There were no significant differences in hypertension, bradycardia, accidental extubation and delirium between the two groups during sedation treatment, but the incidence of hypotension in RASS group was higher than that in NTI group [35.7% (15/42) vs. 13.3% (6/45), P < 0.05]. Compared with RASS group, epinephrine, norepinephrine and the levels of CRP at treatment of 6 hours with light sedation and 2 hours after tracheal catheter removal in NTI group were decreased [epinephrine (pg/L): 138.35±18.60 vs. 157.50±19.91, 136.24±40.40 vs. 150.46±20.22; norepinephrine (pg/L): 347.34±45.46 vs. 393.75±49.77, 340.59±50.95 vs. 376.37±49.70; CRP (μg/L): 62.26±18.78 vs. 71.31±10.32, 53.30±14.47 vs. 64.26±14.69, all P < 0.05], and cortisol level 6 hours after treatment with light sedation was lower than that of RASS group (nmol/L: 327.03±41.04 vs. 358.12±70.01, P < 0.05).

CONCLUSIONS: The application of NTI monitoring to guide light sedation therapy for patients with short-term mechanical ventilation after pancreaticoduodenectomy can better achieve the goal of light sedation.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang M, Yuan J, Chen Q, et al. [Application of Narcotrend index and Richmond agitation-sedation score in sedation assessment of patients with short-term mechanical ventilation after pancreatoduodenectomy: a randomized controlled trial]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31315733. doi:10.3760/cma.j.issn.2095-4352.2019.06.015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。